-
Je něco špatně v tomto záznamu ?
International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study
G. Bahat, B. Ilhan, T. Erdogan, MM. Oren, MA. Karan, H. Burkhardt, M. Denkinger, D. Garfinkel, AJ. Cruz-Jentoft, Y. Morrissey, G. Onder, F. Pazan, E. Tommelein, E. Topinkova, N. van der Velde, M. Petrovic
Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2008-06-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 2008-06-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2008-06-01 do Před 1 rokem
Psychology Database (ProQuest)
od 2008-06-01 do Před 1 rokem
- MeSH
- delfská metoda MeSH
- konsensus MeSH
- lidé MeSH
- nevhodné předepisování * prevence a kontrola MeSH
- senioři MeSH
- Check Tag
- lidé MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: Explicit screening tools and implicit evaluation methods have been developed to assist healthcare professionals in the management of pharmacotherapy in older adults. As prescribing habits and locally available medications vary considerably between countries, guides tailored to the needs of specific regions may be required. We aimed to report the results of the international Delphi validation study for the Turkish Inappropriate Medication use in the Elderly (TIME) criteria set, which aims to detect inappropriate prescribing in older adults in Eastern Europe. METHODS: The study was conducted between June 2019 and March 2020. Delphi rounds were conducted by the TIME international working group, which included 11 internationally recognized experts in geriatric pharmacotherapy as Delphi panelists. They were asked to indicate to what extent they agreed or disagreed with each TIME criterion, taking into account both the available evidence and their own experience. We used a five-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) and an online software program (SurveyMonkey®) to grade the level of agreement. Criteria with a median value of 1 or 2 and a 75th centile value of 1 or 2 were accepted, and criteria with a median value > 2 were rejected. Those with a median value of 1 or 2 but a 75th centile value > 2 were retained, to be assessed in the following round. The initial list of Delphi criteria comprised 153 TIME items. RESULTS: After three Delphi rounds, 134 criteria were accepted and seven criteria were rejected, while 12 criteria did not achieve consensus, and so were not included in the final validated set of TIME criteria. CONCLUSION: We developed the internationally validated TIME criteria set based on a Delphi process involving international experts. The validation study suggests that the TIME criteria set can be applied in both central and Eastern European settings. Further studies are needed to assess the utility and benefit of the TIME criteria in reducing inappropriate drug use and improving clinical outcomes.
Department of Geriatrics 1st Faculty of Medicine Charles University Prague Czech Republic
Department of Public Health Istanbul Medical School Istanbul University Capa 34390 Istanbul Turkey
East Kent Hospitals University NHS Foundation Trust Ethelbert Road Canterbury Kent CT1 3NG UK
Faculty of Health and Social Sciences South Bohemian University České Budějovice Czech Republic
Geriatric Center Ulm Alb Donau Agaplesion Bethesda Ulm Geriatric Research Ulm University Ulm Germany
Section of Geriatrics Department of Internal Medicine and Paediatrics Ghent University Ghent Belgium
Servicio de Geriatría Hospital Universitario Ramón y Cajal Madrid Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004984
- 003
- CZ-PrNML
- 005
- 20230425171832.0
- 007
- ta
- 008
- 230418s2021 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s40266-021-00855-5 $2 doi
- 035 __
- $a (PubMed)33847948
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Bahat, Gülistan $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey. gbahatozturk@yahoo.com $1 https://orcid.org/0000000160395866
- 245 10
- $a International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study / $c G. Bahat, B. Ilhan, T. Erdogan, MM. Oren, MA. Karan, H. Burkhardt, M. Denkinger, D. Garfinkel, AJ. Cruz-Jentoft, Y. Morrissey, G. Onder, F. Pazan, E. Tommelein, E. Topinkova, N. van der Velde, M. Petrovic
- 520 9_
- $a OBJECTIVE: Explicit screening tools and implicit evaluation methods have been developed to assist healthcare professionals in the management of pharmacotherapy in older adults. As prescribing habits and locally available medications vary considerably between countries, guides tailored to the needs of specific regions may be required. We aimed to report the results of the international Delphi validation study for the Turkish Inappropriate Medication use in the Elderly (TIME) criteria set, which aims to detect inappropriate prescribing in older adults in Eastern Europe. METHODS: The study was conducted between June 2019 and March 2020. Delphi rounds were conducted by the TIME international working group, which included 11 internationally recognized experts in geriatric pharmacotherapy as Delphi panelists. They were asked to indicate to what extent they agreed or disagreed with each TIME criterion, taking into account both the available evidence and their own experience. We used a five-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) and an online software program (SurveyMonkey®) to grade the level of agreement. Criteria with a median value of 1 or 2 and a 75th centile value of 1 or 2 were accepted, and criteria with a median value > 2 were rejected. Those with a median value of 1 or 2 but a 75th centile value > 2 were retained, to be assessed in the following round. The initial list of Delphi criteria comprised 153 TIME items. RESULTS: After three Delphi rounds, 134 criteria were accepted and seven criteria were rejected, while 12 criteria did not achieve consensus, and so were not included in the final validated set of TIME criteria. CONCLUSION: We developed the internationally validated TIME criteria set based on a Delphi process involving international experts. The validation study suggests that the TIME criteria set can be applied in both central and Eastern European settings. Further studies are needed to assess the utility and benefit of the TIME criteria in reducing inappropriate drug use and improving clinical outcomes.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a delfská metoda $7 D003697
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nevhodné předepisování $x prevence a kontrola $7 D057970
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ilhan, Birkan $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey
- 700 1_
- $a Erdogan, Tugba $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey
- 700 1_
- $a Oren, Meryem Merve $u Department of Public Health, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey
- 700 1_
- $a Karan, Mehmet Akif $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey
- 700 1_
- $a Burkhardt, Heinrich $u IVth Medical Department, Medical Faculty Mannheim, University Medical Center, Heidelberg University, Mannheim, Germany
- 700 1_
- $a Denkinger, Michael $u Geriatric Center Ulm/Alb-Donau, Agaplesion Bethesda Ulm, Geriatric Research Ulm University, Ulm, Germany
- 700 1_
- $a Garfinkel, Doron $u Center for Appropriate Medication Use, Sheba Medical Center and Deputy Head, Homecare Hospice, Israel Cancer Association, 55 Ben Gurion Road, Bat, 5932210, Yam, Israel
- 700 1_
- $a Cruz-Jentoft, Alfonso J $u Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
- 700 1_
- $a Morrissey, Yvonne $u East Kent Hospitals University NHS Foundation Trust, Ethelbert Road, Canterbury, Kent, CT1 3NG, UK
- 700 1_
- $a Onder, Graziano $u Department of Cardiovascular, Endocrine-metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy
- 700 1_
- $a Pazan, Farhad $u Medical Faculty Mannheim, Institute of Clinical Pharmacology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany
- 700 1_
- $a Tommelein, Eline $u Department Pharmaceutical Sciences (FARM)-Laboratory Pharmaceutical Chemistry, Drug Analysis and Drug Information (FASC), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Jette, Belgium
- 700 1_
- $a Topinkova, Eva $u Department of Geriatrics, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Faculty of Health and Social Sciences, South Bohemian University, České Budějovice, Czech Republic
- 700 1_
- $a van der Velde, Nathalie $u Department of Internal Medicine, Geriatrics, Amsterdam Public Health Research Institute, Amsterdam University Medical Center, Amsterdam, The Netherlands
- 700 1_
- $a Petrovic, Mirko $u Section of Geriatrics, Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium
- 773 0_
- $w MED00001454 $t Drugs & aging $x 1179-1969 $g Roč. 38, č. 6 (2021), s. 513-521
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33847948 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171828 $b ABA008
- 999 __
- $a ok $b bmc $g 1925213 $s 1191193
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2021 $b 38 $c 6 $d 513-521 $e 20210413 $i 1179-1969 $m Drugs &aging $n Drugs Aging $x MED00001454
- LZP __
- $a Pubmed-20230418
